Echoing a longstanding anti-vaccine trope, President Donald Trump falsely claimed that the American vaccine schedule "long ...
Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as it seeks to expand a vaccines business currently ...
6don MSN
Inside the FDA's vaccine uproar
A memo from Dr. Vinay Prasad, the head of the FDA's Center for Biologics Evaluation and Research, may signal an effort to to ...
The Vaccine Adverse Event Reporting System (VAERS) was established to protect public health. Now it's being used against it.
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
MedPage Today on MSNOpinion
The Midterms Are Coming. Vaccines May Play a Role.
Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...
Sanofi agreed to buy Dynavax Technologies Corp for about US$2.2 billion, as the French drugmaker tries to expand a vaccines ...
The Manila Times on MSN
Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal
SANOFI said on Wednesday it will buy US biotech Dynavax Technologies for around $2.2 billion (1.9 billion euros) in an agreed deal that will add an adult hepatitis B vaccine and a promising ...
The Texas Department of Agriculture last Thursday convened agricultural, veterinary, and epidemiological leaders from across Latin America to address the growing threat posed by the New World ...
Dr. Vinay Prasad: "The establishment, the people who set the policies, they have to strive to get things right. They need to do studies. They need to be held to the highest standard." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback